Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1998
03/10/1998US5726287 One step, simple, efficient
03/10/1998US5726286 Isolated epstein-barr virus BZLF2 proteins that bind MHC class II beta chains
03/10/1998US5726200 Treatment of obesity, gastrointestinal disorders, tumors, drug withdrawal; useful as antipsychotic, antianxiety, antiulcer agents;
03/10/1998US5726192 Platelet aggregation inhibiting compounds
03/10/1998US5726182 Treatment of bacterial infections
03/10/1998US5726169 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
03/10/1998US5726166 Inositol monophosphate or a phosphatidyl inositol
03/10/1998US5726160 Treatment of diseases such as cystic fibrosis, emphysema, bronchitis and sinusitis
03/10/1998US5726159 Peptide thrombin inhibitors
03/10/1998US5726158 Peptide derivatives
03/10/1998US5726156 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
03/10/1998US5726155 Lmwg=low molecular weight gtp-binding proteins; inhibiting superoxide production in phagocytic cells; treating inflammation, autoimune disorders, gout, adult respiratory distress syndrome, asthma, myocardial infarction,
03/10/1998US5726154 Stabilization and oral delivery of calcitonin
03/10/1998US5726153 Synthetic peptides for arterial imaging
03/10/1998US5726151 Purified form of streptogramins, its preparation and pharmaceutical compositions containing it
03/10/1998US5726149 Treatment of glomerulonephritis with decorin
03/10/1998US5726148 Method of treating metabolic bone diseases with an IL-1 receptor
03/10/1998US5726147 Human mutant tissue factor compositions useful as tissue factor antagonists
03/10/1998US5726058 Purified dna molecule having specified nucleotide sequence
03/10/1998US5726045 Materials and methods for converting DNA to CO-DNA
03/10/1998US5726037 Host cells and method of producing soluble analogues of integrins
03/10/1998US5726036 Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
03/10/1998US5726035 Recombinant production of mammalian calcium channel gamma subunits
03/10/1998US5726027 Method for treatment of insulin resistance
03/10/1998US5726023 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
03/10/1998US5726020 Inhibition of II synthesis
03/10/1998US5726018 Nucleic acid based assays to detect a novel mammalian protein associated with uncontrolled cell division
03/10/1998US5725864 Contacting susceptible lymphoid cells with antiviral amount of iron-binding protein or derivative thereof
03/10/1998US5725862 Vaccine for branhamelia catarrhalis
03/10/1998US5725860 Method for reducing the risk of developing diabetes
03/10/1998US5725858 Methods of enhancing production performance of birds comprising administration of heterologous protein comprising avian alpha-subunit inhibin protein
03/10/1998US5725856 Anticarcinogenic agents and antitumor agents
03/10/1998US5725855 Method of treating tumors with CD8+ -depleted or CD4+ T cell subpopulations
03/10/1998US5725854 Administering cells and immunology
03/10/1998US5725852 Cytidine diphosphate choline absorption promoter
03/10/1998US5725851 Method and compositions for treating injury
03/10/1998US5725850 Use of CSF-1 to treat tumor burden
03/10/1998US5725839 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI
03/10/1998CA1339709C Monoclonal antibodies to human pancreatic cancer
03/10/1998CA1339707C Formulations for recombinant beta-interferon
03/05/1998WO1998008979A1 Method and compounds for controlling capacitative calcium ion entry into mammalian cells
03/05/1998WO1998008969A1 Soluble interleukin-1 receptor accessory molecule
03/05/1998WO1998008965A2 Cd95 regulatory gene sequences and transcription factors
03/05/1998WO1998008957A1 Compositions and methods for specifically targeting tumors
03/05/1998WO1998008956A2 Use of a mutated macrolide binding protein for the prevention of gvhd
03/05/1998WO1998008955A1 Stimulus-inducible i (kappa)b kinase [ikk] signalsome
03/05/1998WO1998008953A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
03/05/1998WO1998008951A1 New brucella antigens, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
03/05/1998WO1998008950A1 Novel monocyte activating cytokine
03/05/1998WO1998008949A1 P-selectin ligand proteins
03/05/1998WO1998008943A1 Hla-drb1 peptides with specific binding affinity for hla-dq molecules: prevention and treatment of rheumatoid arthritis
03/05/1998WO1998008875A1 Novel combination preparations and their use in immunodiagnosis and immunotherapy
03/05/1998WO1998008873A1 Use of glucagon-like peptide-1 (glp-1) or analogs to abolish catabolic changes after surgery
03/05/1998WO1998008872A1 Glp-2 derivatives
03/05/1998WO1998008871A1 Glp-1 derivatives
03/05/1998WO1998008870A1 Interleukin-19
03/05/1998WO1998008869A1 Hematopoietic stem cell growth factor (scgf)
03/05/1998WO1998008868A1 MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS
03/05/1998WO1998008867A1 Novel peptide derivatives having thiazolyl-alanine residue
03/05/1998WO1998008866A1 Bau, a bin1 interacting protein, and uses therefor
03/05/1998WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
03/05/1998WO1998008863A1 Enzyme and dna sequence encoding same
03/05/1998WO1998008861A1 Rp compositions and therapeutic and diagnostic uses therefor
03/05/1998WO1998008859A1 Bioconjugates and delivery of bioactive agents
03/05/1998WO1998008840A1 Integrin antagonists
03/05/1998WO1998008829A1 Pharmaceutical compounds
03/05/1998WO1998008548A2 Stable radioiodine conjugates and methods for their synthesis
03/05/1998WO1998008545A1 Methods for treating disorders by using interleukin-9 and its antagonists
03/05/1998WO1998008542A2 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998WO1998008541A1 Inhibition of primary and/or secondary immune response to repeat adenoviral vector administration using cd40l specific antibodies
03/05/1998WO1998008538A1 Use of hyaluronidase
03/05/1998WO1998008537A1 Enhanced stimulation of erythropoiesis
03/05/1998WO1998008536A2 Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity
03/05/1998WO1998008535A2 Method of causing selective immunosuppression using hl-60-related lectins
03/05/1998WO1998008534A1 Lymphocyte-derived antimicrobial protein (ldap) and methods of isolating and producing and using the protein
03/05/1998WO1998008533A1 Sustained peptide-release formulation
03/05/1998WO1998008532A1 Methods of treating renal disease with a gastrin releasing peptide receptor antagonist
03/05/1998WO1998008531A1 Use of glp-1 or analogs in treatment of myocardial infarction
03/05/1998WO1998008530A1 Mhc peptides and methods of use
03/05/1998WO1998008529A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008528A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008512A1 Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor
03/05/1998WO1998008492A1 Transdermal delivery of peptides
03/05/1998WO1998008490A1 Solid coprecipitates for enhanced bioavailability of lipophilic substances
03/05/1998WO1998004717A3 Double-stranded rna dependent protein kinase derived peptides to promote proliferation of cells and tissues in a controlled manner
03/05/1998WO1998002548A3 Infectious papillomavirus pseudoviral particles
03/05/1998WO1998002452A3 Compounds and methods for modulating cell adhesion
03/05/1998WO1998001554A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1998001553A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1998001552A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1998000532A3 Oligonucleotides from the untranslated regions of ribonucleotide reductase and their use to modulate cell growth
03/05/1998WO1997037690A3 Cytomodulating conjugates of members of specific binding pairs
03/05/1998WO1997037688A3 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
03/05/1998DE19636328A1 Use of human leukocyte antigen aggregates and/or antigen units
03/05/1998DE19634730A1 Bispecific antibodies, useful for imaging, diagnosis and treatment
03/05/1998CA2265088A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
03/05/1998CA2264548A1 Interleukin-19
03/05/1998CA2264309A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998CA2264297A1 Pharmaceutical compounds
03/05/1998CA2263999A1 Integrin antagonists